Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder
Clinical trial NCT01074294 · COMPLETED
Trial details
- NCT number
- NCT01074294
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-16
- Primary completion
- 2011-06-20
- Enrollment
- 740
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.